Global Birch Allergy Treatment Market Poised for Strong Growth: Expected to Reach USD 1123.24 Million by 2033 at a CAGR 7%

The global birch allergy treatment market is experiencing significant growth, with a market value of USD 571 million in 2023. Projections indicate that the market is set to nearly double, reaching USD 1123.24 Million by 2033. This impressive growth reflects a compound annual growth rate (CAGR) of 7% during the forecast period from 2023 to 2033.

Birch pollen allergy, a common seasonal affliction affecting millions globally, has driven the demand for effective treatments in recent years. With a growing awareness of allergy-related health issues, coupled with advancements in immunotherapy and drug development, the birch allergy treatment market is positioned for substantial expansion.

One of the most promising developments in the Birch Allergy Treatment Market is the use of immunotherapy. Immunotherapy is a treatment that involves exposing a patient to gradually increasing doses of an allergen, such as birch pollen. The idea behind this treatment is to desensitize the patient’s immune system to the allergen, which can help reduce or even eliminate allergic reactions.

In addition to traditional treatment options, there has also been a growing interest in alternative therapies for the treatment of birch allergy. These therapies include acupuncture, herbal remedies, and homeopathy. While the efficacy of these treatments is still being studied, they have shown promising results in some cases and may provide additional treatment options for birch allergy sufferers.

Key Takeaways from the Market Study:

  • The Birch allergy treatment market is expected to grow at a value of 7% CAGR in the forecast period 2023-2033
  • Oral route of administration is expected to hold 53% of the market share in 2023 for Birch allergy treatment market.
  • North America is expected to possess 48% market share for Birch allergy treatment market in 2023.
  • Europe Birch allergy treatment market size is expected to possess 43% market share in 2023.

“Significant increase in the number of drugs and therapies available for the treatment of birch allergy is not only increasing treatment options for patients but has also has made treatments more effective and efficient.” states an FMI analyst

Heightened Demand for Market Data: Our Full Report Provides Extensive Trend Analysis!

Competitive Landscape:

Key players in the Birch allergy treatment market are Allergy Therapeutics Plc, Regeneron Pharmaceuticals Inc, Desentum, HAL Allergy Group, Roxall Medizin GmbH, Worg Pharmaceuticals AG, S-TARget therapeutics GmbH, Adamis Pharmaceuticals Corporation, Merck KGaA and Stallergenes Greer plc

  • Allergy Therapeutics Plc is a biopharmaceutical company that specializes in developing immunotherapy products for the treatment of allergies, including birch allergy. The company has developed a range of products for the treatment of birch allergy, including subcutaneous and sublingual immunotherapies.
  • Desentum’s product for birch allergy is called ASIT+TM Birch, which is a vaccine that combines Desentum’s proprietary peptide-based technology with an adjuvant to enhance the immune response.

Key Segments Profiled in the Birch Allergy Treatment Market Industry Survey:

Drug Class:

  • Antihistamines
  • Cetirizine
  • Diphenhydramine
  • Decongestant
  • Pseudoephedrine
  • Oxymetazoline

Route of Administration:

  • Oral
  • Intranasal

Distribution Channel:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Cancer Vaccines Market Set to Reach USD 24.22 Billion by 2033, Growing at a Robust CAGR of 12%: FMI Study

The global cancer vaccines market is poised for remarkable growth, with an expected market value of USD 9 billion in 2023. According to recent market projections, the industry is set to expand significantly, reaching USD 24.22 billion by 2033, driven by a compound annual growth rate (CAGR) of 12% during the forecast period from 2023 to 2033.

The cancer vaccine market is driven by factors such as increasing incidence of cancer, growing awareness about cancer vaccines, and government initiatives to promote cancer research and development. One of the key factors driving the growth of the cancer vaccine market is the increasing incidence of cancer worldwide. This is due to a variety of factors, such as aging populations, changing lifestyle patterns, and environmental factors. As the incidence of cancer continues to rise, there is a greater need for effective cancer treatments, including cancer vaccines.

Government initiatives are also playing a significant role in driving the growth of the cancer vaccine market. Governments around the world are investing heavily in cancer research and development, which has led to increased funding for cancer vaccine development and clinical trials. For example, the US government has launched the Cancer Moonshot initiative, which aims to accelerate cancer research and improve cancer treatment and prevention.

Key Takeaways from the Market Study:

  • The market for cancer vaccines expanded at a 9% CAGR from 2018 to 2022.
  • The market for cancer vaccines is anticipated to expand at a 12% CAGR from 2023 to 2033.
  • The market for cancer vaccines is anticipated to reach USD 24.22 billion by 2033.
  • Recombinant cancer vaccines have the biggest market share, according to the Future Market Insights research.
  • For the market for cancer vaccines, North America is anticipated to hold a 40% market share.
  • With a share of 20% throughout the projection period, it is expected that the East & South Asia market would grow considerably.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Cancer Vaccines.” says an FMI analyst

Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!

Market Competition:

Key players in the market include companies such as Advaxis Inc., Amgen Inc., Dynavax Technologies Corporation, Generex Biotechnology Corporation, GlaxoSmithKline plc, Immunocellular Therapeutics, Ltd, Merck & Co., Inc., Vaccinogen, Inc., F Hoffmann-La Roche AG, and  OSE Immunotherapeutics, along with healthcare providers and technology companies among other global players.

  • In January 2023, the U.K. government announced a collaboration with BioNTech, a German company, to trial potential vaccines for cancer and other illnesses, while campaigners cautioned that any breakthrough must remain affordable and accessible. Personalized mRNA therapies, including cancer vaccines that aim to activate the immune system against harmful cells, will be tested on cancer patients in England at both early and late stages. The therapies target active cancer cells and work to prevent their return. BioNTech will establish new research and development centers in the U.K., including a laboratory in Cambridge and a headquarters in London, and aim to supply 10,000 therapies to patients from September 2023 until the end of the decade.

The firm developed one of the most widely-distributed Covid-19 vaccines in collaboration with U.S. pharmaceutical firm Pfizer. The collaboration will cover various cancer types and infectious diseases affecting collectively hundreds of millions of people worldwide.

Key Segments Profiled in the Cancer Vaccines Industry Survey

Technology:

  • Recombinant Cancer Vaccines
  • Whole-cell Cancer Vaccines
  • Viral Vector & DNA Cancer Vaccines
  • Antigen/Adjuvant Cancer Vaccines

Treatment Method:

  • Preventive Vaccine
  • Therapeutic Vaccine

Application:

  • Prostate Cancer
  • Cervical Cancer
  • Other Applications

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Self-Ligating Brackets Market Set for Remarkable Growth, Expected to Reach USD 717.1 Million by 2033 expand at a CAGR of 6.6%

The global self-ligating brackets market, a transformative advancement in orthodontic technology, is projected for substantial growth over the next decade. According to the latest market report, the sector, valued at USD 355.4 million in 2022, is anticipated to rise to USD 377.9 million by 2023. The market is set to experience a robust expansion, reaching an impressive USD 717.1 million by 2033, reflecting a steady compound annual growth rate (CAGR) of 6.6% from 2023 to 2033.

Self-ligating brackets are revolutionizing orthodontic care by eliminating the need for traditional elastic ligatures used to attach archwires to brackets. These advanced fixtures feature an integrated mechanism that securely holds the archwire in place, significantly reducing friction between the wire and the brackets. This innovative design offers numerous advantages over conventional braces, including enhanced patient comfort and shorter treatment times.

This offers a number of advantages over traditional braces, including:

  • Reduced treatment time: Self-ligating brackets can reduce treatment time by up to 25% compared to traditional braces. This is because they create less friction between the archwire and the bracket, allowing teeth to move more freely.
  • Improved comfort: Self-ligating brackets are more comfortable than traditional braces because they do not require elastic ligatures, which can put pressure on the gums and teeth.
  • Better aesthetics: Self-ligating brackets are less noticeable than traditional braces because they do not have elastic ligatures. This is especially beneficial for adults who may be self-conscious about wearing braces.

The growing demand for cosmetic dentistry is one of the key drivers of the self-ligating bracket sales market. As more and more people are looking for ways to improve their appearance, they are turning to orthodontic treatment to straighten their teeth. Self-ligating brackets are a popular choice for cosmetic dentistry because they offer a number of advantages over traditional braces, including reduced treatment time, improved comfort, and better aesthetics.

Another key driver of the self-ligating bracket sales market is the increasing prevalence of malocclusion (misaligned teeth or jaws). Malocclusion is a common condition that can affect people of all ages. It can be caused by a number of factors, including genetics, environmental factors, and thumb sucking. Self-ligating brackets are an effective treatment for malocclusion, and they are becoming increasingly popular among orthodontists.

Interest in Market Trends: Get Detailed Analysis and Insights with Our Comprehensive Report!

Key Takeaways:

  • The self-ligating bracket sales market is expected to grow at a CAGR of 6.6% over the forecast period, from USD 377.9 Million in 2023 to USD 717.1 Million by 2033.
  • The growing demand for cosmetic dentistry and the increasing prevalence of malocclusion are the key drivers of the market.
  • Active self-ligating brackets are the most popular type of self-ligating bracket, and they are expected to remain the dominant segment over the forecast period.
  • Dental clinics are the largest application segment, and they are expected to remain the dominant segment over the forecast period.
  • North America is the largest regional market, and it is expected to remain the dominant segment over the forecast period.

The self-ligating bracket sales market is poised for significant growth in the coming years. The growing demand for cosmetic dentistry and the increasing prevalence of malocclusion are the key drivers of the market. The key players in the market are focusing on developing new products and technologies to meet the growing demand for self-ligating brackets.

Key Companies Profiled:

  • 3M
  • Dentsply Sirona
  • Great Lakes Orthodontics
  • Ormco Corporation
  • Rocky Mountain Orthodontics
  • BioMers Pte Ltd
  • American Orthodontics
  • G&H(r) Orthodontics
  • All-Star Orthodontics
  • Biocetec Co., Ltd.
  • Forestadent Bernhard Forster GmbH
  • Biomaterials Korea, Inc.

Key Segments Covered in the Industry Research:

Product:

  • Active Self-Ligating Brackets
  • Passive Self-Ligating Brackets

Indication:

  • Metal
  • Ceramic

End User:

  • Hospitals
  • Dental Clinics
  • Group Dental Practices
  • Academic & Research Institutions

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Biliary Tract Cancers (BTCs) Treatment Market Poised for Significant Growth, Reaching USD 4.74 Billion by 2033 registering a CAGR of 4%

The global biliary tract cancers (BTCs) treatment market is on an impressive growth trajectory, according to the latest report by Future Market Insights (FMI). Projected to reach a market value of USD 3.2 billion by the end of 2023, the sector is expected to expand further, achieving USD 4.74 billion by 2033. This growth is driven by a steady Compound Annual Growth Rate (CAGR) of 4% over the next decade, offering substantial opportunities for stakeholders within the industry.

BTCs encompass a rare and aggressive group of cancers affecting the biliary system, including the bile ducts, gallbladder, and liver. Despite the inherent challenges associated with late-stage diagnosis, advancements in diagnostic techniques and treatment modalities have significantly improved patient outcomes and survival rates.

FMI’s comprehensive report highlights a growing demand for innovative treatment strategies, emphasizing the critical need for ongoing investment in research and development. As the incidence of BTCs continues to rise globally, healthcare systems and industry stakeholders are presented with unique opportunities to drive forward advancements in treatment approaches.

Key findings from the report indicate a notable increase in BTCs cases, with an estimated 12,000 new cases reported in the United States in 2020 alone. Additionally, the rising adoption of minimally invasive procedures is expected to drive market growth, offering patients less invasive treatment options.

However, the market faces hurdles such as high treatment costs and limited awareness among patients and healthcare providers. Overcoming these challenges will require concerted efforts, including government initiatives aimed at raising awareness and funding research and development in BTCs treatment.

“The projected growth of the global biliary tract cancers treatment market underscores the pressing need for continued innovation and awareness in the field,” commented FMI. “By investing in research and education, stakeholders can work towards improving outcomes for patients affected by BTCs.”

Key Takeaways from the Market Study:

  • The market for treatments for biliary tract cancers (BTCs) expanded at a CAGR of 3% from 2018 to 2022.
  • Between 2023 and 2033, the market for biliary tract cancers (BTCs) treatment is anticipated to expand at a 4% CAGR.
  • The market for treating biliary tract cancers (BTCs) is anticipated to reach USD 4.74 billion by 2033.
  • The injectable market share is the greatest, according to the Future Market Insights research.
  • In the market for biliary tract cancers (BTCs) treatments, North America is anticipated to hold a 40% market share.
  • The East & South Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.

Accelerated Market Demand: Find Comprehensive Insights and Trends in Our Full Report!

Market Competition:

Key players in the market include companies such as Incyte Corporation, Loxo Oncology, Bayer, Roche, Genentech, Agios Pharmaceuticals, Servier Pharmaceuticals, Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, Eisai, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Zymeworks, and BeiGene, along with healthcare providers and technology companies among other global players.

  • In September 2022, Durvalumab (Imfinzi, AstraZeneca UK Limited) was granted approval by the Food and Drug Administration on September 2, 2022 for treating adult patients with locally advanced or metastatic biliary tract cancer (BTC) in combination with gemcitabine and cisplatin. In the TOPAZ-1 (NCT03875235) trial, which was a randomized, double-blind, placebo-controlled, multiregional study, the efficacy of the treatment was evaluated. The trial enrolled 685 patients who had histologically confirmed locally advanced unresectable or metastatic BTC and who had not previously undergone systemic therapy for advanced disease.

The demographics of the trial showed that 56% were Asian, 37% were White, 2% were Black, and 4% were of other races, while 7% were Hispanic or Latino. In terms of gender, 50% were male and 50% were female, with a median age of 64 years (ranging from 20-85). 47% of the participants were 65 years or older. In the trial, 56% of patients had intrahepatic cholangiocarcinoma, 25% had gallbladder cancer, and 19% had extrahepatic cholangiocarcinoma.

Key Segments Profiled in the Biliary Tract Cancers (BTCs) Treatment Industry Survey:

Drug Class:

  • Durvalumab
  • Zanidatamab
  • Ramucirumab

Route of Administration:

  • Inhalation
  • Intravenous
  • Intranasal
  • Subcutaneous
  • Oral
  • Parenteral

Molecule type:

  • Antibody
  • Antisense oligonucleotides
  • Immunotherapy
  • Monoclonal antibody
  • Peptides
  • Protein
  • Small molecule
  • Stem Cell

Product Type:

  • Mono
  • Combination
  • Mono/Combination

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Wilson’s Disease Diagnostics Market Set to Reach USD 896 Million by 2033, Driven by Technological Advancements and Rising Prevalence: FMI Study

The global wilson’s disease diagnostics market is poised for significant growth, with an expected market value of USD 611.16 million in 2023. This market is projected to reach USD 896 million by 2033, reflecting a compound annual growth rate (CAGR) of 3.9% during the forecast period from 2023 to 2033.

Wilson’s disease, a rare genetic disorder caused by copper accumulation in the liver, brain, and other organs, is becoming more recognized, driving the demand for accurate diagnostic solutions. The increasing prevalence of the condition, coupled with advancements in diagnostic technologies, is expected to be a key driver for the market’s growth.

Technological innovations, including the integration of advanced testing methods, are enhancing the accuracy and efficiency of Wilson’s disease diagnostics, offering improved outcomes for early detection and treatment. Furthermore, the market has shown consistent growth, registering a CAGR of 3% from 2018 to 2022, indicating a steady rise in both awareness and diagnostic capabilities.

As the global healthcare sector continues to prioritize precision medicine and early intervention, the Wilson’s disease diagnostics market is expected to benefit from ongoing advancements and growing healthcare investments. This market is well-positioned to witness further growth as healthcare providers continue to adopt cutting-edge diagnostic tools to address the challenges posed by this rare yet impactful disease.

Key Takeaways from the Market Study:

  • The Wilson’s disease diagnostics market is expected to grow at a value of 3.9% CAGR in the forecast period 2023 to 2033
  • By distribution channel, hospital pharmacies are expected to hold 43% of the market share in 2023 for Wilson’s disease diagnostics market.
  • North America is expected to possess 46% market share for Wilson’s disease diagnostics market in 2023.
  • Europe Wilson’s disease diagnostics market size is expected to possess 37% market share in 2023.

“With continued investment in research and development, it is likely that new diagnostic tools and techniques will be developed, leading to improved outcomes and quality of life for patients with Wilson’s disease.” states an FMI analyst

Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!

Competitive Landscape:

Key players in the Wilson’s diseases diagnostics market are Orphalan, AstraZeneca, Vivet Therapeutics, Pfizer, Ultragenyx Pharmaceutical, Valeant Pharmaceuticals International, Inc., Noblepharma Co., Ltd., Merck & Co., Inc., Teva Pharmaceuticals, Wilson Therapeutics AB

  • Ultragenyx Pharmaceutical is a biopharmaceutical company that has been involved in the development of a diagnostic test for Wilson’s disease called WDx. The WDx test is a blood test that measures the levels of ceruloplasmin, a protein that binds to copper in the blood. Low levels of ceruloplasmin are a characteristic feature of Wilson’s disease, and the WDx test can aid in the diagnosis of the condition.
  • In 2018, Wilson Therapeutics AB was acquired by Alexion Pharmaceuticals, a biopharmaceutical company focused on the development of treatments for rare diseases. Following the acquisition, Alexion continued the development of WTX101 and submitted the drug for regulatory approval in the United States and Europe. In 2018, the US FDA granted WTX101 Breakthrough Therapy designation for the treatment of Wilson’s disease.

Key Segments Profiled in the Wilson’s Disease Diagnostics Industry Survey:

Drug Class:

  • Penicillamine
  • Trientine
  • Tetrathiomolybdate

Route of Administration:

  • Oral
  • Parenteral

Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Pediatric Obesity Management Market to Reach USD 4.74 Billion by 2033, Driven by Increased Demand for Comprehensive Treatment Solutions | FMI

The global pediatric obesity management market is poised for significant growth, with an expected market value of USD 3.2 Billion in 2023. As the prevalence of childhood obesity continues to rise globally, the market is projected to expand at a compound annual growth rate (CAGR) of 4%, reaching an estimated value of USD 4.74 Billion by 2033.

Pediatric obesity has become a critical public health issue, with long-term implications for children’s overall health. As the condition becomes more prevalent, there is an increasing demand for effective management strategies, which is driving the market’s growth. In the historical period from 2018 to 2022, the market recorded a CAGR of 3%, reflecting the growing awareness and need for intervention.

The Pediatric Obesity Management market offers a comprehensive range of products and services aimed at providing effective treatment and management for this growing concern. Key offerings include lifestyle modifications, behavioral therapy, medications, and bariatric surgery, all of which are tailored to address the unique challenges of managing obesity in children. These treatments not only help in controlling the condition but also play a pivotal role in improving the overall health and well-being of affected children.

Healthcare providers, along with parents and caregivers, are increasingly adopting a multi-faceted approach to pediatric obesity management, combining both medical and lifestyle interventions to ensure long-term success. With a focus on holistic care, the market is expected to continue its upward trajectory, offering innovative and personalized solutions to combat childhood obesity.

As the market evolves, there is a growing emphasis on developing new treatment options and strategies that will further enhance the effectiveness of managing pediatric obesity. The global Pediatric Obesity Management Market is set to play a crucial role in combating one of the most pressing health issues facing children today.

Key Takeaways from the Market Study:

  • The market for paediatric obesity management expanded at a CAGR of 3% between 2018 and 2022.
  • From 2023 to 2033, the global market for paediatric obesity management is anticipated to expand at a 4% CAGR.
  • The Pediatric Obesity Management Market is anticipated to generate USD 4.74 billion by 2033.
  • According to the FMI analysis, hospital pharmacies account for the largest market share.
  • In terms of market share for paediatric obesity management, North America is predicted to hold 40% of the market.
  • With a share of 20% throughout the projection period, it is expected that the East & South Asia market would grow considerably.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Pediatric Obesity Management.” says an FMI analyst

Surge in Market Demand: Explore Comprehensive Trends and Analysis in Our Full Report!

Market Competition:

Key players in the market include companies such as Pfizer Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc., AstraZeneca, Herbalife Ltd., Apollo Endosurgery, Ethicon, Inc., Takeda Pharmaceutical Company, VIVUS Inc., Currax Pharmaceuticals LLC, along with healthcare providers and technology companies among other global players.

  • The U.S. Food and Drug Administration approved the use of Wegovy (semaglutide) injection (2.4 mg once weekly) as a medication for chronic weight control in individuals with obesity or those who are overweight with at least one weight-related disease, such as high blood pressure, high cholesterol, or type 2 diabetes, in June 2021. The medication can be taken along with a lower calorie diet and more exercise. Since 2014, this subcutaneous injection is the first medication to be licenced for managing chronic weight in individuals who are obese or overweight. Patients with a body mass index (BMI) of 27 kg/m2 or above who have at least one weight-related condition, as well as those with a BMI of 30 kg/m2 or more, are advised to use it.

Key Segments Profiled in the Pediatric Obesity Management Industry Survey:

Drug Class:

  • Lorcaserin
  • Liraglutide
  • Phentermine
  • Setmelanotide
  • Others

Route of Administration:

  • Oral
  • Injectable

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Severe Asthma Treatment Market Poised for Significant Growth, Expected to Reach USD 36.18 Billion by 2033: FMI Study

The global severe asthma treatment market is experiencing robust growth and is forecasted to continue its upward trajectory over the next decade. The market, valued at USD 22 billion in 2023, is expected to reach USD 36.18 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.1% from 2023 to 2033.

This impressive market expansion can be attributed to several key factors, including the rising prevalence of asthma and the broadening range of treatment options available to patients worldwide. The increasing number of asthma cases, particularly severe asthma, has prompted heightened demand for effective and innovative treatment solutions, driving growth across the market.

In the historical period from 2018 to 2022, the severe asthma treatment market grew at a steady CAGR of 3.3%, laying the foundation for the anticipated surge in market value. The continued development of novel biologic therapies and advancements in personalized treatment plans are expected to further fuel this expansion.

Key Market Drivers:

  • Increasing Prevalence of Asthma: With asthma rates on the rise globally, there is an urgent need for better treatment options to manage severe cases.
  • Diverse Treatment Options: The market is benefiting from a wide array of therapeutic alternatives, from inhaled corticosteroids to advanced biologics, providing patients with more effective management solutions.
  • Innovation in Treatment Modalities: Ongoing research and development efforts are bringing new treatments to market, improving the quality of life for individuals living with severe asthma.

As the market continues to evolve, industry experts predict that severe asthma treatment options will become increasingly specialized, helping to better address the unique needs of asthma patients. With continued advancements in drug development and treatment protocols, the future of severe asthma care looks promising, offering hope for millions of individuals suffering from this chronic condition.

Key Takeaways from the Market Study

  • Severe asthma treatment market is expected to register a CAGR of 5.1% in the forecast period 2023-2033
  • Inhaled route of administration is expected to possess 40% market share for severe asthma treatment market in 2023.
  • North America is expected to possess 45% market share for severe asthma treatment market in 2023.
  • Europe severe asthma treatment market size is expected to possess 39% market share in 2023.

“Advancements in treatments along with innovation of treatment options is expected to favor the growth of the market in the upcoming years.” states an FMI analyst

Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report!

Competitive Landscape:

Key players in the severe asthma treatment market are Teva Pharmaceutical, AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Regeneron Pharmaceutical, 4D Pharma plc, AB Pharma, Morphosys, Roche, Avalo Therapeutics, Suzhou Connect Biopharmaceuticals, Pieris Pharma, Biosion

  • GlaxoSmithKline most significant contributions to the treatment of severe asthma has been the development and commercialization of a biologic medication called Nucala (mepolizumab). Nucala is an anti-IL-5 monoclonal antibody that is used to treat severe eosinophilic asthma, a type of severe asthma that is characterized by high levels of eosinophils in the blood and airways.
  • Novartis’ most significant contributions to the treatment of severe asthma has been the development and commercialization of a biologic medication called Xolair (omalizumab). Xolair is an anti-IgE monoclonal antibody that is used to treat severe allergic asthma, a type of severe asthma that is triggered by allergens such as pollen, dust mites, and animal dander.

Key Segments Profiled in the Severe Asthma Treatment Industry Survey

Drug Class:

  • Reslizumab
  • Benralizumab
  • Anti-inflammatory

Route of Administration:

  • Oral
  • Inhaled
  • Intravenous
  • Subcutaneous

Device Type:

  • Dry powder inhalers
  • Metered dose inhalers
  • Soft mist inhalers

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa(MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market Set to Surge, Valued at USD 13.1 Billion by 2033 expand at a CAGR of 17.4%

According to the latest industry analysis by Future Market Insights, the global clinical next-generation sequencing (NGS) data analysis market, valued at approximately USD 2.3 billion in 2022, is on track for remarkable expansion. The market is projected to experience substantial growth with a Compound Annual Growth Rate (CAGR) of 17.4%, reaching an estimated valuation of around USD 13.1 billion by 2033.

The exponential growth in the clinical NGS data analysis market is driven by several key factors. The increasing prevalence of cancer, a growing geriatric population, and the rise in lifestyle diseases worldwide are significantly boosting the demand for advanced genomic analysis tools. As healthcare systems worldwide strive to address these challenges, the need for sophisticated genomic analysis solutions becomes ever more critical.

The escalating demand for precise and quick sequencing interpretation tools and algorithms is expected to drive market growth significantly. These tools play a crucial role in accelerating data processing, enabling healthcare professionals to make informed decisions and improve patient outcomes.

As the clinical NGS data analysis market continues to evolve, companies are focusing on developing innovative solutions to address the growing needs of healthcare providers and researchers. Advanced bioinformatics tools and algorithms are anticipated to play a pivotal role in unlocking new insights into complex diseases and driving advancements in personalized medicine.

Key Takeaways from Market Study:

  • NGS data analysis & sequencing services is the leading segment as solution and services, and is anticipated to hold a CAGR of 15.2% between 2023 & 2033, owing to affordability of NGS data analysis & sequencing services.
  • Sequencing by synthesis (SBS) segment by technology holds a market value share of around 42.7% in 2022, because of its capabilities, which include long-insert paired-end reads for efficient sequence assembly, de novo sequencing, and other applications.
  • Medical research dominates in term of application of clinical next-generation sequencing (NGS) data analysis with a projected market value share of around 39.6% in 2022, owing to increasing sequencing based approaches.
  • By end user, academic & research institutes held a share of around 37.7% in 2022, due to increasing adoption of NGS platforms.
  • North America held a value share of around 40.6% in 2022, owing to the advancements made in personalized medicines, NGS, and companion diagnostics in the region.

“The development of next-generation sequencing (NGS) technologies and their increased use in genomic research, clinical diagnosis and personalized treatment for a numerous diseases are driving up the demand for exact and rapid sequencing interpretation tools and algorithms speeding up data analysis, which result in increased market demand,” says an analyst of Future Market Insights.

Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!

Market Competition:

The COVID-19 pandemic had a favorable effect on the clinical next-generation sequencing (NGS) data analysis industry, due to the increased implementation of next-generation sequencing (NGS) technology.  NGS technology was also used to identify new coronavirus strains and other diseases.

The overall demand for the healthcare sector has increased because of the increased demand. In light of the increased demand for COVID-19-related research, the clinical next-generation sequencing (NGS) data analysis market experienced a jump in demand during the height of the pandemic.

  • In September 2022, QIAGEN and Neuron23 collaborated to develop next-generation sequencing companion diagnostics for a novel Parkinson’s disease drug.
  • In March 2022, Thermo Fisher Scientific launched the Ion Torrent Genexus Dx Integrated Sequencer, an automated next-generation sequencing (NGS) platform.

Key Companies Profiled:

  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific
  • BGI Group
  • Qiagen
  • Roche Diagnostics
  • DNAStar, Inc.
  • Bio-Rad Laboratories, Inc.
  • Congenica Ltd.
  • Theragen Etex Inc.
  • PerkinElmer, Inc.
  • Partek Inc.
  • Oxford Nanopore Technologies PLC.
  • Pacific Biosciences of California, Inc.
  • Golden Helix, Inc.
  • BioDatomics
  • PierianDx

Key Market Segments Covered in the Clinical Next-Generation Sequencing (NGS) Data Analysis Industry Research:

Solution and Services:

  • NGS Data Analysis Tools
    • Sequence Alignment Tools
    • Alignment Visualization Tools
    • Gene Prediction Tools
    • Variant Analysis Tools
    • Others
  • Platforms
    • Next-Generation Sequencing (NGS) Platforms
    • Clinical Informatics Platforms
    • Others
  • NGS Data Analysis & Sequencing Services
    • Whole-Genome Sequencing (WGS)
    • Whole Exome Sequencing (WES)
    • Comprehensive genomic profiling (CGP)
    • Custom Panels
    • RNA Sequencing
    • Other Sequencing Services
  • NGS Storage, Management & Cloud Computing Platform

Technology:

  • Sequencing by Synthesis (SBS)
  • Nanopore Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing
  • Others

Application:

  • Diagnostics
  • Drug Discovery & Designing
  • Medical Research
  • Others

End User:

  • Hospitals & Clinics
  • Academic Institutes & Research Centers
  • Biotechnology Companies
  • Life Science Technology Vendors
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:         

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Printing Machinery Market to Reach USD 38,572.8 Million, Globally by 2033 at 4.7% CAGR: Future Market Insights, Inc.

The global Printing Machinery Market is likely to expand at 4.7% CAGR over the forecast period. The industry’s size is predicted to surge from USD 22,814.9 Million in 2023 to USD 38,572.8 Million by 2033.

A vast proportion of readers are continuously shifting toward online mediums. Due to the proliferation of the internet and subsequent rise in digital platforms like Amazon Kindle and Kobo. As a result, the printing machinery industry is poised to exhibit a dynamic shift.

Manufacturers involved in the industry are leveraging the surge in packaging products. The burst of e-commerce sites in the last few years has created a huge demand for packaging and labels. Both packaging and label not only protect the final product but also promote the brand. Therefore, companies are greatly working towards creating unique packaging solutions that effectively purvey the brand’s beliefs and values.

Dive Deeper into the Data—View the Full Report Here!

Future Market Insights has estimated that the packaging industry is projected to attain nearly half of the overall market share, in terms of end-use.

For commercial purposes, printing machinery is still finding applications. They are used for businesses like advertising, retail, marketing, and other commercial businesses.

Fabric, a type of substrate, requires a durable textile printer to manufacture high-quality products. Printed fabrics can be commonly seen as a form of packaging. In June 2022, the apparel industry proposed the digitalization of physical labels on clothes.

The issue was raised on grounds of lack of accessibility to sight-impaired consumers, inflicting irritation to people with sensitive skin, and chemical-based inks. In the future, these tags are expected to take the form of a QR code, taking a cue from rampant digitalization.

Top Highlights:

  • The North American market holds a monumental position in the printing machinery industry. This region is closely rivaled with Europe, which accounts for 24.2%, as compared to the 25.8% market share North America held in 2022.
  • Within North America, the United States is projected to represent a colossal share of the industry. In 2022, the country held a 21.1% market share and generated substantial revenue for the overall market.
  • Germany has held a share of 6.1% globally. The country has been significantly contributing toward regional growth and is expected to continue doing so.
  • China and India are vigorous markets for printing machinery in the Asia Pacific. India is estimated to account for 7.6% CAGR and China is estimated to expand at 5.6% CAGR in the next 10 years.
  • Based on product type, offset lithography grabbed a 49.2% market share in 2022.
  • The packaging industry attained a total of 42.1% market share in 2022.

Key Developments Inducing the Market Growth:

  • Epson America, Inc. extended its EcoTank line printing solutions in 2021. The new solutions are intended for home offices and creative professionals. The firm introduced EcoTank Photo ET-8550 and ET-8500 for crafters, creatives, scrapbookers, professional graphics, and graphic design solutions.
  • Memjet launched a new technology named DuraFlex in 2020. This technology helps produce industry-leading quality and speed in an affordable range. Due to the modular design of DuraFlex, OEMs can manufacture printing equipment. Making them commercially available in a relatively short period.

Top Manufacturers:

  • Agfa-Gevaert NV
  • Oce NV
  • Bobst Group SA
  • Fujifilm Holdings Corporation
  • Heidelberger Druckmanschinen AG
  • HP Inc.
  • Koening & Bauer AG
  • Komori Corporation
  • Apex Machine Company Inc.
  • Officine Meccaniche Giovanni Cerutti S.p.A.

Printing Machinery Market by Category

By Product Type:

  • Offset Lithography
  • Flexography
  • Screen
  • Gravure
  • Letterpress
  • Digital
  • Others

By Substrate Type:

  • Plastic
  • Paper & Paperboard
  • Metal
  • Other Substrates (Wood, Glass, Fabric)

By Application:

  • Packaging & Labels
  • Books
  • Newspaper & Magazines
  • Commercial Printing & Others
  • Advertising
  • Office Stationaries

By End Use:

  • Commercial
  • Publication
  • Packaging

By Region:

  • North America
  • Latin America
  • Europe
  • Japan
  • Asia Pacific
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Paper Bag Market is Predicted to Reach USD 8.7 Billion, Globally by 2034 at 4.3% CAGR: Future Market Insights, Inc.

The global paper bag market is on a robust growth trajectory, with its valuation expected to rise from USD 5.6 billion in 2024 to USD 8.7 billion by 2034, marking a steady CAGR of 4.3% over the forecast period. The surge in demand for eco-friendly packaging solutions across various industries is a key factor propelling market growth.

Several governments are considering taxing plastic bags or prohibiting their use altogether. Such a move is expected to significantly fuel the paper bag market, leading to the increasing adoption of paper Bag as a packaging material. The latest sustainable production techniques and the development of biodegradable coatings also influence the future of the paper bag industry. These advancements are likely to play a crucial role in shaping the industry.

Backtrack for Better Insights: Access the Old Source of This Report Here!

The demand for paper Bag has increased due to the rising popularity of online purchasing and home delivery services. Paper Bag are the perfect option, considering a growing number of consumers are shopping online and need sturdy, lightweight packing for their items.

Key Market Highlights:

  • Rising Demand Across Multiple Industries:The demand for paper bags is escalating due to their cost-effectiveness, customizability, and availability in diverse sizes and designs. Retail and eCommerce businesses are leading this growth by adopting paper bags as packaging solutions, thereby enhancing the unboxing experience for consumers.
  • Smart Paper Bags: The increasing popularity of smart paper bags is transforming modern packaging applications. These innovative bags, which enable clinical monitoring and smart packaging, allow merchants to track packages and provide product data to customers via QR codes, opening up new opportunities for market expansion.
  • Sustainability and Government Regulations: The global shift towards sustainability is a significant driver for the paper bag market. Government regulations on single-use plastic bags have further accelerated the adoption of eco-friendly alternatives like paper bags. Key industry players are embracing sustainable practices to meet the growing consumer demand for environmentally friendly packaging.
  • eCommerce and Online Purchasing: The surge in online purchasing and home delivery services has significantly increased the demand for paper bags. As more consumers shop online, there is a heightened need for sturdy, lightweight packaging solutions, making paper bags the perfect option for various items.

Key Takeaways from the Paper Bag Market

  • The global paper bag market is estimated to register a CAGR of 4.3% and reach a valuation of USD 8.7 billion by 2034.
  • The brown kraft paper segment commands a substantial market share of 73.2% in 2024, emerging as the predominant choice.
  • The demand for paper bags in India is anticipated to expand at a CAGR of 6.3% through 2034.
  • With a 5.7% CAGR through 2034, China is expected to drive the global market.
  • The market in Thailand is anticipated to secure a CAGR of 5.2% during the forecast period.
  • The paper bag industry in the United Kingdom is predicted to grow at a CAGR of 3.9% through 2034.

Competition Analysis

The paper bag companies focus on innovation to meet changing consumer demands and market dynamics. They heavily invest in research and development activities to create eco-friendly bags that are more durable and functional and have enhanced strength, designs, and sizes.

Some companies are also expanding their production capacity through new facilities and acquisitions. Customization options like printing logos and promotional messages on bags are also offered to meet the branding requirements of different clients.

Key Companies in the Paper Bag Market

  • Mondi Plc
  • Smurfit Kappa Group Plc
  • International Paper Company
  • Novolex Holdings, Inc.
  • Ronpak
  • Welton Bibby And Baron Limited
  • Prompac LLC.
  • Langston Companies, Inc.
  • United Bag, Inc.
  • Genpak Flexible
  • Global-Pak, Inc.
  • York Paper Company Limited
  • PaperBag Limited
  • JohnPac Inc

Recent Developments in the Paper Bag Market

  • In November 2023, Biopax, a sustainable packaging firm in West Belfast, announced the installation of a modern paper wrap machine, boosting domestic paper wrap production by 500 million units annually.
  • In October 2023, Primark continues its reusable gift packaging initiative with craft paper bags for the festive season.
  • In September 2023, Marks & Spencer switched from plastic bags for life to eco-friendly paper carrier bags for the reduction of its carbon footprint and alignment with its sustainability commitment.

Market Segmentation: Paper Bag

By Product:

  • Sewn Open Mouth
  • Pinched Bottom Open Mouth
  • Pasted Valve
  • Pasted Open Mouth
  • Flat Bottom

By Material Type:

  • Brown Kraft
  • White Kraft

By Thickness:

  • 1 ply
  • 2 ply
  • 3 ply
  • Greater than 3 ply

By End Use:

  • Agriculture & Allied Industries
  • Building & Construction
  • Food & Beverage
  • Retail
  • Chemicals
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube